Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Galera Therapeutics Inc.

    OTC: GRTX · Real-Time Price · USD
    0.03
    0.00 (9.09%)
    At close: Apr 04, 2025, 2:24 PM

    Galera Therapeutics Statistics

    Share Statistics

    Galera Therapeutics has 75.46M shares outstanding. The number of shares has increased by 38.74% in one year.

    Shares Outstanding

    n/a
    		 75.46M

    Shares Change (YoY)

    n/a
    		 38.74%

    Shares Change (QoQ)

    n/a
    		 38.74%

    Owned by Institutions (%)

    n/a
    		 0.1%

    Shares Floating

    n/a
    		 31.8M

    Failed to Deliver (FTD) Shares

    n/a
    		 72,275

    FTD / Avg. Volume

    n/a
    		 68.5%

    Short Selling Information

    The latest short interest is 2.12M, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.12M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 5.32%

    Short Ratio (days to cover)

    n/a
    		 1.16

    Valuation Ratios

    The PE ratio is -0.13 and the forward PE ratio is -0.04. Galera Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.13

    Forward PE

    n/a
    		 -0.04

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.02

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Galera Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6

    Quick Ratio

    n/a
    		 6

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,708,142.86

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -203K

    Effective Tax Rate

    n/a
    		 1.06%

    Stock Price Statistics

    The stock price has increased by -81.48% in the last 52 weeks. The beta is 2.06, so Galera Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.06

    52-Week Price Change

    n/a
    		 -81.48%

    50-Day Moving Average

    n/a
    		 0.04

    200-Day Moving Average

    n/a
    		 0.06

    Relative Strength Index (RSI)

    n/a
    		 29.87

    Average Volume (20 Days)

    n/a
    		 105,505

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -3.84M

    Operating Income

    n/a
    		 -20.16M

    Net Income

    n/a
    		 -18.96M

    EBITDA

    n/a
    		 -20.16M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.35
    Full Income Statement

    Balance Sheet

    The company has 8.29M in cash and 0 in debt, giving a net cash position of 8.29M.

    Cash & Cash Equivalents

    n/a
    		 8.29M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -456.36M

    Total Assets

    n/a
    		 8.9M

    Working Capital

    n/a
    		 7.99M
    Full Balance Sheet

    Cash Flow

    Operating Cash Flow

    n/a
    		 n/a

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 n/a

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    GRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GRTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -77.23

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist